Destiny Pharma to participate in panel discussion at the Cantor Antibiotics Summit, New York, USA on 17th January 2018

Dr Bill Love, Chief Scientific Officer and Founder of Destiny Pharma, will participate in the panel discussion titled ‘Novel Ways to Treat and/or Address Infections’ at the Cantor Antibiotics Summit in New York on Wednesday 17 January 2018. If you would like to meet with Bill, please email us on conferences@destinypharma.com.